(NP (NP (NP (NN Drug) (NNS Names)) (, ,) (NP (NNP Population) (NNP Level) (NNP Surveillance)) (CC and) (NP (NP (DT the) (NNP FDA) (POS 's)) (NNP Adverse) (NNP Event) (VBG Reporting) (NN System))) (: :) (NP (NP (NP (NP (NP (DT An) (NNP Exploratory) (NNP Data) (NNP Survey)) (PP (IN of) (NP (NNP Drug) (NNP Name) (NNP Incidence) (CC and) (NNP Prevalence)))) (, ,) (NP (JJ 2004-2012Q2))) (NP (NN Purpose))) (: :) (S (VP (TO To) (VP (VB count) (CC and) (VB monitor) (NP (NP (DT the) (NN drug) (NNS names)) (VP (VBN reported) (PP (IN in) (NP (NP (NP (NP (DT the) (ADJP (RB publicly) (JJ available)) (NN version)) (PP (IN of) (NP (DT the) (NNP Federal) (NNP Adverse) (NNP Event) (NNP Reporting) (NNP System)))) (PRN (-LRB- -LRB-) (NP (NNP FAERS)) (-RRB- -RRB-))) (PP (PP (IN from) (NP (CD 2004))) (PP (TO to) (NP (CD 2012Q2)))))))) (PP (IN in) (NP (DT a) (JJ maximized) (NN sensitivity) (JJ relational) (NN model))))))) (. .))
(NP (NP (NNS Methods)) (: :) (S (S (NP (NP (NNP Data) (NN mining)) (CC and) (NP (NNS data) (NN modeling))) (VP (VBD was) (VP (VBN conducted)))) (CC and) (S (NP (NP (ADJP (NN event) (VBN based)) (JJ summary) (NNS statistics)) (PP (IN with) (NP (NNS plots)))) (VP (VBD were) (VP (VBN created) (PP (IN from) (NP (NP (QP (IN over) (CD nine)) (JJ continuous) (NNS years)) (PP (IN of) (NP (JJ continuous) (NNP FAERS) (NNS data))))))))) (. .))
(NP (NP (NNS Results)) (: :) (S (NP (DT This) (NNP FAERS) (NN model)) (VP (VBZ contains) (NP (NP (NP (CD 344,452) (JJ individual) (NN drug) (NNS names)) (CC and) (NP (CD 432,541,994) (NN count) (NNS references))) (SBAR (WHNP (WDT which)) (S (VP (VBD occurred) (PP (IN across) (NP (CD 4,148,761) (JJ human) (NNS subjects))) (PP (IN in) (NP (DT the) (ADJP (CD 34) (NN quarter)) (NN study) (NN period))))))))) (. .))
(S (S (NP (NP (NNS Plots)) (PP (IN for) (NP (DT the) (JJ top) (CD 100) (VBG scoring) (NN drug) (NN name) (NNS references)))) (VP (VBP are) (VP (VBN reported) (PP (IN by) (NP (NN year) (CC and) (NN quarter)))))) (: ;) (S (NP (DT the) (JJ top) (CD 100) (NN drug) (NNS names)) (VP (VBP contain) (NP (NP (CD 143,384,240) (NNS references)) (CC or) (NP (NP (CD 33) (NN %)) (PP (IN of) (NP (DT all) (NN drug) (NN name) (VBZ references)))) (PP (IN over) (NP (NP (CD 34) (NNS quarters)) (PP (IN of) (NP (JJ continuous) (NNP FAERS) (NNS data)))))))) (. .))
(NP (NP (NNS Conclusions)) (: :) (S (SBAR (IN While) (S (NP (NNP FAERS)) (VP (VBZ contains) (NP (JJ many) (NX (NX (NNS drugs)) (CC and) (NX (JJ adverse) (NN event) (NNS reports))))))) (, ,) (NP (PRP$ its) (NNS data)) (VP (NNS pertains) (PP (TO to) (NP (NP (RB very) (JJ few)) (PP (IN of) (NP (PRP them))))))) (. .))
(S (NP (NN Drug) (NN name) (NN incidence)) (VP (VP (VBZ lends) (NP (NP (ADJP (RB timely) (CC and) (JJ effective)) (NN surveillance)) (PP (IN of) (NP (NP (JJ large) (NNS populations)) (PP (IN of) (NP (NNP Averse) (NNP Event) (NNPS Reports))))))) (CC and) (VP (VBZ does) (RB not) (VP (VB require) (S (NP (NP (NP (DT the) (NN cause)) (PP (IN of) (NP (DT the) (NNP AE)))) (, ,) (CC nor) (NP (PRP$ its) (NN validity))) (VP (TO to) (VP (VB be) (VP (VBN known) (S (VP (TO to) (VP (VB detect) (NP (DT a) (NN mass) (NN poisoning)))))))))))) (. .))
